ImQuest Gains Dual-Mechanism HIV Compounds From Samjin

Though its only a month into a strategic drug development agreement between ImQuest Pharmaceuticals Inc. and Samjin Pharmaceutical Co. Ltd., the alliance already has yielded its first licensing deal. (BioWorld Today)